Scorecard
| Current Price | Overvalued | |
| Yield (%) – Higher is better Current Yield: 0.60% Industry Average: 3.39% | ||
| Dividend Growth (%) – Higher is better Dividend Growth: 15.38% Industry Average: 6.41% | ||
| Returns (%) – Higher is better Returns: 55.89% Industry Average: 18.17% | ||
| Free Cash Flow Payout Ratio (%) – Lower is better FCFPR: 109.27% Industry Average: 51.48% | ||
ELI LILLY AND COMPANY
(XNYS:LLY)
Industry: Pharmaceuticals
| Price | Change (Daily) |
| $ 1,153.69 | $ -28.18 |
Dividend
Annual Dividend | Annual Yield |
$ 6.92 | 0.60 % |
Dividend Streak | 5 Year Average |
11 year(s) | 1.04 % |
Fair Price
Current Stock price is considered: Overvalued
| Current Price ● $ 1,153.69 |
| Less Than $486.23 | $486.23 – $926.06 | More Than $926.06 |
| Undervalued | Fair Price | Overvalued |
Using average Dividend Yield for stock valuation. Learn about this method for Fair Price analysis HERE.
Growth
Dividend Growth Rate
1 Year | 3 Year | 5 Year |
15.38 % | 15.24 % | 15.18 % |
| 2021 | 2022 | 2023 | 2024 | 2025 |
| $ 3.40 | $ 3.92 | $ 4.52 | $ 5.20 | $ 6.00 |
Price Return
1 Year | 5 Year | CAGR 5 Years |
$ 413.62 55.89 % | $ 910.19 | 36.50 % |